Interleukin-6 IL-6 SARS-CoV-2 Basic Panel Test
Comprehensive COVID-19 Diagnostic Assessment
The Interleukin-6 IL-6 SARS-CoV-2 Basic Panel Test represents a cutting-edge diagnostic approach to COVID-19 management, combining viral detection with comprehensive inflammatory and organ function assessment. This advanced panel provides healthcare providers with critical data to evaluate disease severity, monitor progression, and guide treatment decisions for patients affected by SARS-CoV-2 infection.
What This Test Measures and Detects
Our comprehensive panel evaluates multiple critical parameters essential for COVID-19 management:
- SARS-CoV-2 RT-PCR: Direct detection of viral RNA to confirm active infection
- Interleukin-6 (IL-6): Key inflammatory cytokine that drives cytokine storm in severe COVID-19
- C-Reactive Protein (CRP): Acute phase reactant indicating systemic inflammation
- D-Dimer: Critical marker for thrombosis risk and coagulopathy
- Ferritin: Indicator of hyperinflammation and macrophage activation
- Complete Blood Count (CBC) with NLR: Assessment of immune cell populations and neutrophil-to-lymphocyte ratio
- Liver Function Tests (LFT): Evaluation of hepatic involvement and drug metabolism capacity
- Kidney Function Tests (KFT): Monitoring renal function and potential acute kidney injury
- Prothrombin Time (PT): Assessment of coagulation status and bleeding risk
Who Should Consider This Test
This comprehensive panel is recommended for individuals experiencing:
- COVID-19 symptoms including fever, cough, shortness of breath, or loss of taste/smell
- Confirmed COVID-19 diagnosis requiring severity assessment
- High-risk patients with comorbidities (diabetes, hypertension, obesity)
- Progressive respiratory symptoms suggesting potential cytokine storm
- Unexplained fatigue, muscle aches, or gastrointestinal symptoms
- Patients requiring hospitalization or monitoring for disease progression
- Individuals with abnormal initial COVID-19 test results
Clinical Benefits and Importance
The Interleukin-6 IL-6 SARS-CoV-2 Basic Panel provides numerous clinical advantages:
- Early Risk Stratification: Identifies patients at risk for severe disease progression
- Treatment Guidance: Helps determine appropriate therapeutic interventions including anti-IL-6 therapy
- Progression Monitoring: Tracks disease evolution and response to treatment
- Complication Prediction: Assesses risk for thrombosis, organ dysfunction, and cytokine storm
- Comprehensive Assessment: Provides holistic view of viral, inflammatory, and organ status
- Evidence-Based Management: Supports clinical decision-making with objective laboratory data
Understanding Your Test Results
Interpreting the comprehensive results requires medical expertise, but general guidance includes:
- Elevated IL-6: May indicate cytokine storm and increased risk for severe disease
- High CRP and Ferritin: Suggest significant inflammatory response
- Elevated D-Dimer: Indicates increased thrombosis risk requiring anticoagulation consideration
- Abnormal CBC/NLR: Lymphopenia and elevated NLR correlate with disease severity
- Organ Function Changes: LFT/KFT abnormalities may suggest multi-organ involvement
- Positive SARS-CoV-2 PCR: Confirms active viral infection requiring isolation and management
All results should be discussed with your healthcare provider for proper interpretation and management planning.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $252 |
| Regular Price | $280 |
Convenient Nationwide Access
GGC DNA has testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures accessible COVID-19 testing with rapid turnaround times.
Advanced Testing Methodology
Our panel utilizes state-of-the-art laboratory techniques including Real Time RT-PCR for viral detection, Electrical Impedance and VCS for hematological analysis, Spectrophotometry and Indirect ISE for biochemical parameters, Immunoturbidimetry for inflammatory markers, Photo-optical clot detection for coagulation studies, and ECLIA/CLIA for precise cytokine measurement.
Sample Collection and Processing
Multiple sample types are required for comprehensive analysis:
- Serum from SST tube (3 mL minimum)
- Plasma from EDTA tube (2 mL minimum)
- Whole blood from EDTA tube (3 mL)
- Citrated plasma for coagulation studies
- Nasopharyngeal and oropharyngeal swabs in viral transport medium
All samples are processed with strict quality control measures and shipped under appropriate temperature conditions to ensure result accuracy.
Book Your Test Today
Take control of your health with our comprehensive COVID-19 assessment panel. Early detection and monitoring can significantly impact disease outcomes and recovery. Contact us today to schedule your Interleukin-6 IL-6 SARS-CoV-2 Basic Panel Test.
Call or WhatsApp: +1(267) 388-9828
Our experienced healthcare team is ready to assist you with testing coordination, result interpretation, and follow-up care recommendations. Don’t wait – proactive COVID-19 management starts with accurate diagnostic information.
